Trial intelligence / Profile preview

Sitagliptin and Saxagliptin Effect on Beta-cell Function in T2DM

NCT02386943Phase 4Unknown

Sponsor
Shanghai Jiao Tong University School of Medicine
Start
Dec 2013
Primary completion
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of sitagliptin and saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by Shanghai Jiao Tong University School of Medicine. Status: unknown.

02

Drugs

sitagliptinsaxagliptin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT02386943.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02386943.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call